New triple-threat treatment tested for tough-to-treat gynecologic cancers
Disease control
Ongoing
This study is testing whether combining three existing cancer drugs works better than current options for women whose endometrial, ovarian, fallopian tube, or primary peritoneal cancer has returned or stopped responding to platinum chemotherapy. The trial will enroll 38 participa…
Phase: PHASE2 • Sponsor: Floor Backes, MD • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC